Published July 31, 2015 | Version v1
Journal article

Ectopic expression of anti-HIV-1 shRNAs protects CD8+ T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation

  • 1. Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA (United States)
  • 2. Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA (United States)
  • 3. Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA (United States)
  • 4. AIDS Healthcare Foundation, Los Angeles, CA (United States)
  • 5. UCLA AIDS Institute, Los Angeles, CA (United States)

Description

Chimeric antigen receptors (CARs) are artificially engineered receptors that confer a desired specificity to immune effector T cells. As an HIV-1-specific CAR, CD4ζ CAR has been extensively tested in vitro as well as in clinical trials. T cells modified with this CAR mediated highly potent anti-HIV-1 activities in vitro and were well-tolerated in vivo, but exerted limited effects on viral load and reservoir size due to poor survival and/or functionality of the transduced cells in patients. We hypothesize that ectopic expression of CD4ζ on CD8+ T cells renders them susceptible to HIV-1 infection, resulting in poor survival of those cells. To test this possibility, highly purified CD8+ T cells were genetically modified with a CD4ζ-encoding lentiviral vector and infected with HIV-1. CD8+ T cells were vulnerable to HIV-1 infection upon expression of CD4ζ as evidenced by elevated levels of p24Gag in cells and culture supernatants. Concurrently, the number of CD4ζ-modified CD8+ T cells was reduced relative to control cells upon HIV-1 infection. To protect these cells from HIV-1 infection, we co-expressed two anti-HIV-1 shRNAs previously developed by our group together with CD4ζ. This combination vector was able to suppress HIV-1 infection without impairing HIV-1-dependent effector activities of CD4ζ. In addition, the number of CD4ζ-modified CD8+ T cells maintained similar levels to that of the control even under HIV-1 infection. These results suggest that protecting CD4ζ-modified CD8+ T cells from HIV-1 infection is required for prolonged HIV-1-specific immune surveillance. - Highlights: • Ectopic expression of CD4ζ CAR in CD8+ T cells renders them susceptible to HIV-1 infection. • Co-expression of two anti-HIV-1 shRNAs protects CD4ζ CAR-modified CD8+ T cells from HIV-1 infection. • Protecting CD4ζ CAR-modified CD8+ T cells from HIV-1 infection suppresses its cytopathic effect

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2015.05.026

Additional details

Identifiers

DOI
10.1016/j.bbrc.2015.05.026;
PII
S0006-291X(15)00940-7;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
463
Journal Issue
3
Journal Page Range
p. 216-221
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47031708
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
AIDS VIRUS; ANTIGENS; CELL PROLIFERATION; IMMUNOTHERAPY; IN VITRO; IN VIVO; INSPECTION; MEDICAL SURVEILLANCE; MONITORING; PATIENTS; RECEPTORS; RNA; SPECIFICITY; VECTORS
Descriptors DEC
MEDICINE; MEMBRANE PROTEINS; MICROORGANISMS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; PARASITES; PROTEINS; TENSORS; THERAPY; VIRUSES

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.